Company Profile
ChemScene can order timely high quality and efficient services of various compounds from mg to kg level for some clients' bioscience research......
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
(+)-JQ-1 |
6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetic acid,4-(4-chlorophenyl)-2,3,9-trimethyl-,1,1-dimethylethyl ester,(6S)-;1,1-Dimethylethyl (6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetate;(+)-JQ 1;JQ 1;(S)-(+)-tert-Butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate;JQ1 (pharmaceutical);JQ 1(+);tert-Butyl (S)-2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate;(S)-JQ1;JQ1 (BET inhibitor);BET domain inhibitor JQ1;Bromodomain and extra-terminal domain inhibitor JQ1 |
1268524-70-4 | Inquiry | |
216244-04-1;1alpha, 25-Dihydroxy VD2-D6 |
(1R,3S,5Z)-4-Methylene-5-[(2E)-2-[(1R,3aS,7aR)-octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4-dimethyl-5-(methyl-d3)-2-hexen-1-yl-6,6,6-d3]-7a-methyl-4H-inden-4-ylidene]ethylidene]-1,3-cyclohexanediol;Ercalcitriol, 1a,25-DiOH(D2)-d6;(1R,3S,5Z)-4-Methylene-5-[(2E)-2-[(1R,3aS,7aR)-octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4-dimethyl-5-(methyl-d3)-2-hexen-1-yl-6,6,6-d3]-7a-methyl-4H-inden-4-ylidene]ethylidene]-1,3-cyclohexanediol;1-alpha,25-Dihydroxy Vitamin D2-d6;Ercalcitriol-d6;1alpha, 25-Dihydroxy VD2-D6 |
216244-04-1 | Inquiry | |
78782-98-6;Calcifediol-D6 |
Calcifediol-d6;(3β,5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-3,25-diol-d6;25-Hydroxycholecalciferol-d6;25-HydroxyvitaMin D3-d6;25-HydroxyvitaMin D-d6;Calcidiol-d6;Didrogyl-d6;Hidroferol-d6 |
78782-98-6 | Inquiry | |
78782-99-7;Calcitriol D6 |
(1a,3,5Z,7E)- 9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol-d6;1a,25-Dihydroxycholecalciferol-d6;1a,25-Dihydroxyvitamin D3-d6;Calcijex-d6;Calcitriol-d6;Ro 21-5535-d6;Rocaltrol-d6;Silkis-d6 |
78782-99-7 | Inquiry | |
Abiraterone；CB-7598; CB7598;CB 7598 |
Androsta-5,16-dien-3-ol,17-(3-pyridinyl)-,(3β)-;(3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol;CB 7598;Abiraterone;17-(3-Pyridinyl)-androsta-5,16-dien-3β-ol |
154229-19-3 | Inquiry | |
ABT 737;ABT 737;ABT737 |
Benzamide,4-[4-[(4′-chloro[1,1′-biphenyl]-2-yl)methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(dimethylamino)-1-[(phenylthio)methyl]propyl]amino]-3-nitrophenyl]sulfonyl]-;4-[4-[(4′-Chloro[1,1′-biphenyl]-2-yl)methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(dimethylamino)-1-[(phenylthio)methyl]propyl]amino]-3-nitrophenyl]sulfonyl]benzamide;ABT 737 |
852808-04-9 | Inquiry | |
Afatinib;BIBW-2992; BIBW2992 |
2-Butenamide,N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-,(2E)-;(2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide;Afatinib;BIBW 2992;Tovok;Gilotrif;Giotrif |
850140-72-6 | Inquiry | |
Apremilast;CC 10004 |
Acetamide,N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]-;N-[2-[(1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]acetamide;(S)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione;Apremilast;CC 10004;(S)-N-[2-[1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl]ethyl]-1,3-dioxoisoindolin-4-yl)acetamide;Otezla;666854-78-0 |
608141-41-9 | Inquiry | |
AZD 7762;AZD7762;AZD-7762 |
2-Thiophenecarboxamide,3-[(aminocarbonyl)amino]-5-(3-fluorophenyl)-N-(3S)-3-piperidinyl-;3-[(Aminocarbonyl)amino]-5-(3-fluorophenyl)-N-(3S)-3-piperidinyl-2-thiophenecarboxamide;5-(3-Fluorophenyl)-3-ureidothiophene-2-carboxylic acid N-[(S)-piperidin-3-yl]amide;AZD 7762;1019773-80-8 |
860352-01-8 | Inquiry | |
AZD-1480；AZD1480; AZD 1480 |
5-Chloro-N2-[(1S)-1-(5-fluoro-2-pyrimidinyl)ethyl]-N4-(5-methyl-1H-pyrazol-3-yl)-2,4-pyrimidinediamine;AZD 1480;(S)-5-chloro-N4-(5-Methyl-1H-pyrazol-3-yl)-N2-(1-(5-MethylpyriMidin-2-yl)ethyl)pyriMidine-2,4-diaMine;(S)-5-chloro-N2-(1-(5-fluoropyriMidin-2-yl)ethyl)-N4-(5-Methyl-1H-pyrazol-3-yl)pyriMidine-2,4-diaMine;5-Chloro-N2-[(1S)-1-(5-fluoro-2-pyrimidinyl)ethyl]-N4-(5-methyl-1H-pyrazol-3-yl)-2,4-pyrimidinediamineAZD 1480;AZD 1480 5-Chloro-N2-[(1S)-1-(5-fluoro-2-pyrimidinyl)ethyl]-N4-(5-methyl-1H-pyrazol-3-yl)-2,4-pyrimidinediamine;AZD1480, >=98%;(S)-5-Chloro-N2-(1-(5-fluoropyrimidin-2-yl)ethyl)-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4- |
935666-88-9 | Inquiry | |
AZD-8055；AZD8055; AZD 8055 |
Benzenemethanol,5-[2,4-bis[(3S)-3-methyl-4-morpholinyl]pyrido[2,3-d]pyrimidin-7-yl]-2-methoxy-;5-[2,4-Bis[(3S)-3-methyl-4-morpholinyl]pyrido[2,3-d]pyrimidin-7-yl]-2-methoxybenzenemethanol;[5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[5,6-e]pyrimidin-7-yl]-2-methoxyphenyl]methanol;[5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol;AZD 8055;CCG 168;NVP-CCG 168;[5-[2,4-Bis[(3S)-3-methylmorpholin-4-yl]pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol;AZD-8055;AZD8055 |
1009298-09-2 | Inquiry | |
AZD6482 ；AZD6482;AZD-6482 |
2-[[(1R)-1-[7-methyl-2-(4-morpholinyl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid;(R)-2-(1-(7-Methyl-2-morpholino-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl)ethylamino)benzoic acid;AZD 6482;AZD6482(PI3-kinase β inhibitor);AZD-6482/AZD6482;AZD6482(r);(R)AZD64822-[[(1R)-1-[7-Methyl-2-(4-Morpholinyl)-4-oxo-4h-pyrido[1,2-a]pyriMidin-9-yl]ethyl]aMino]benzoic acid;KIN-193 |
1173900-33-8 | Inquiry | |
Bardoxolone methyl ;NSC 713200; RTA 402; CDDO Methyl esterOleana-1,9(11)-dien-28-oicacid, 2-cyano-3,12-dioxo-, methyl ester; |
Oleana-1,9(11)-dien-28-oic acid,2-cyano-3,12-dioxo-,methyl ester;CDDO-Me;Methyl 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oate;CDDO Methyl ester;RTA 402;NSC 713200;Bardoxolone methyl;2-Cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid methyl ester;2-Cyano-3,12-dioxoolen-1,9-dien-28-oic acid methyl ester;DCL 000217 |
218600-53-4 | Inquiry | |
BYL719;BYL 719; BYL719 |
1,2-Pyrrolidinedicarboxamide,N1-[4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethylethyl)-4-pyridinyl]-2-thiazolyl]-,(2S)-;(2S)-N1-[4-Methyl-5-[2-(2,2,2-trifluoro-1,1-dimethylethyl)-4-pyridinyl]-2-thiazolyl]-1,2-pyrrolidinedicarboxamide;(S)-Pyrrolidine-1,2-dicarboxylic acid 2-amide 1-[4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethylethyl)-pyridin-4-yl]thiazol-2-yl]amide;BYL 719;(S)-Pyrrolidine-1,2- dicarboxylic acid 2-amide- 1-([4-methyl-5-[2-(2,2,2-trifluoro-l,l-dimethyl-ethyl)-pyridin-4- yl]-thiazol-2-yl]-amide);Alpelisib;NVP-BYL 719;(2S)-1-N-[4-Methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide;Piqray;1361185-44-5 |
1217486-61-7 | Inquiry | |
CAL101;CAL101; GS-1101;GS1101;GS 1101;CAL 101 |
4(3H)-Quinazolinone,5-fluoro-3-phenyl-2-[(1S)-1-(9H-purin-6-ylamino)propyl]-;4(3H)-Quinazolinone,5-fluoro-3-phenyl-2-[(1S)-1-(1H-purin-6-ylamino)propyl]-;5-Fluoro-3-phenyl-2-[(1S)-1-(9H-purin-6-ylamino)propyl]-4(3H)-quinazolinone;CAL 101;GS 1101;Idelalisib;Zydelig;N6-[(S)-1-(5-Fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl]adenine;Delalisib;(S)-2-(1-((9H-Purin-6-yl)amino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one |
870281-82-6 | Inquiry | |
Canagliflozin |
D-Glucitol,1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-,(1S)-;(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol;TA 7284;JNJ 28431754;Canagliflozin;JNJ 28431754AAA;JNJ 24831754ZAE;Invokana;1-(β-D-Glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene;(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol;2169850-08-0 |
842133-18-0 | Inquiry | |
Everolimus；RAD001; SDZ-RAD; Certican; Zortress; Afinitor;RAD 001 |
Rapamycin,42-O-(2-hydroxyethyl)-;23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine,rapamycin deriv.;42-O-(2-Hydroxyethyl)rapamycin;40-O-(2-Hydroxyethyl)rapamycin;SDZ-RAD;RAD 001;Everolimus;RAD;Certican;XIENCE V;Afinitor;Zortress;Xience;Afinitor Disperz;Votubia;1245613-55-1;2413306-61-1 |
159351-69-6 | Inquiry | |
GDC-0941；GDC 0941;GDC0941 |
Thieno[3,2-d]pyrimidine,2-(1H-indazol-4-yl)-6-[[4-(methylsulfonyl)-1-piperazinyl]methyl]-4-(4-morpholinyl)-;2-(1H-Indazol-4-yl)-6-[[4-(methylsulfonyl)-1-piperazinyl]methyl]-4-(4-morpholinyl)thieno[3,2-d]pyrimidine;4-[2-(1H-Indazol-4-yl)-6-[[4-(methylsulfonyl)piperazin-1-yl]methyl]thieno[3,2-d]pyrimidin-4-yl]morpholine;GDC 0941;Pictilisib;GDC 941;GNE 0941;1146702-55-7 |
957054-30-7 | Inquiry | |
GDC-0980;GNE 390; GDC 0980; RG 7422 |
(S)-1-[4-[[2-(2-Aminopyrimidin-5-yl)-7-methyl-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-2-hydroxypropan-1-one;GNE 390;GDC-0980;(S)-1-(4-((2-(2-aMinopyriMidin-5-yl)-7-Methyl-4-Morpholinothieno[3,2-d]pyriMidin-6-yl)Methyl)piperazin-1-yl)-2-hydroxypropan-1-one;GDC-0980 (RG7422);Apitolisib;Apitolisib (GDC-0980, RG7422);(S)-1-[4-[[2-(2-Aminopyrimidin-5-yl)-7-methyl-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-2-hydroxypropan-1-one GNE 390GDC0980(RG7422) |
1032754-93-0 | Inquiry | |
GSK1904529A;GSK 1904529A;GSK-1904529A |
GSK1904529A;GSK1904529A : IGF-IR, IGF-IIR inhibitor;N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide;GSK 4529;N-(2,6-difluorophenyl)-5-(3-(2-(5-ethyl-2-methoxy-4-(4-(4-(methylsulfonyl)piperazin-1-yl)piperidin-1-yl)phenylamino)pyrimidin-4-yl)H-imidazo[1,2-a]pyridin-2-yl)-2-methoxybenzamide;N-(2,6-Difluorophenyl)-5-[3-[2-[[5-ethyl-2-(methyloxy)-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]-2-(methyloxy)benzamide GSK 1904529A;GSK1904529A, >=98%;IGF-IR, IGF-IIR inhibitor |
1089283-49-7 | Inquiry |
CONTACT INFORMATION
Sign In for Details